Future Journal of Pharmaceuticals and Health Sciences最新文献_第2页

Virtue of methotrexate in ectopic pregnancy 甲氨蝶呤治疗宫外孕的优点

Future Journal of Pharmaceuticals and Health Sciences Pub Date : 2024-01-28 DOI: 10.26452/fjphs.v4i1.563

Salma Shaik, Lakshmi Manasa Venkata Sai, Kavya Rachamsetty, Dhachinamoorthi Duraiswamy, Rama Chandra Reddy L

{"title":"Virtue of methotrexate in ectopic pregnancy","authors":"Salma Shaik, Lakshmi Manasa Venkata Sai, Kavya Rachamsetty, Dhachinamoorthi Duraiswamy, Rama Chandra Reddy L","doi":"10.26452/fjphs.v4i1.563","DOIUrl":"https://doi.org/10.26452/fjphs.v4i1.563","url":null,"abstract":"In recent times there is a shortfall of care about ectopic pregnancy among everyone, inciting conceded finding and potentially non -violent results. Ectopic pregnancy is a very dangerous medical disorder. This occurs when a fertilised egg implants outside of the uterus, generally in the fallopian tube. Making up 5%–10% of all pregnancy-related deaths, ectopic pregnancies are the leading cause of maternal death in the first trimester. Methotrexate is a folic acid inhibitor. It interferes with DNA synthesis and cell multiplication by inhibiting the spontaneous synthesis of purines and pyrimidines. Methotrexate will be used in the middle of six and eight weeks of pregnancy. The likelihood of a future pregnancy succeeding after using methotrexate is generally positive, according to studies. However, a few things could have an impact on these odds. As per to research, ectopic pregnancies are more common among women of reproductive age, usually between the ages of 20 and 35. Given that they are more likely to be sexually active and trying to get pregnant, women in this age range are at their most fertile. Additionally, the prevalence of sexually transmitted diseases (STIs) is higher in this age group, which can mark up the chance of an ectopic pregnancy. Factors affecting ectopic pregnancy risk include previous pelvic surgeries, infections, in vitro fertilization [IVF], endometriosis, smoking, assisted reproductive technologies, and tubal sterilization or previous pregnancies. This review of the literature attempts to shed insight on how methotrexate is currently used to treat ectopic pregnancies","PeriodicalId":503124,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"402 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140490467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A review on osteoarthritis 骨关节炎综述

Future Journal of Pharmaceuticals and Health Sciences Pub Date : 2023-11-29 DOI: 10.26452/fjphs.v3i4.526

Rabbani Shaik, Surya Sritaja Podila, Ijaz Sheik

引用次数: 0

The prescription pattern for coronary artery disease in tertiary care hospitals 三级医院冠心病处方模式

Future Journal of Pharmaceuticals and Health Sciences Pub Date : 2023-11-24 DOI: 10.26452/fjphs.v3i4.525

Gautham Chakra R, Chandana Sai Y, Jyoshna V, Likhitha K, Tejeswini N, Iswarya N, Naga Lakshmi N

{"title":"The prescription pattern for coronary artery disease in tertiary care hospitals","authors":"Gautham Chakra R, Chandana Sai Y, Jyoshna V, Likhitha K, Tejeswini N, Iswarya N, Naga Lakshmi N","doi":"10.26452/fjphs.v3i4.525","DOIUrl":"https://doi.org/10.26452/fjphs.v3i4.525","url":null,"abstract":"The study aims to assess the current prescribing patterns for drugs managing Coronary Heart Disease (CHD) at the designated site to promote rational drug use in a specialized population. Conducted in the Medicine ward over six months, this observational retrospective study focused on patients consulting cardiologists for cardiac issues. Among lipid-lowering agents, rosuvastatin was the most prescribed (52.84%), followed by atorvastatin (43.15%). Anti-hypertensive agents were widely used, with beta-blockers, ACE inhibitors, and diuretics being popular choices. Adrenergic receptor blockers were common for hypertension, with metoprolol (55.7%) and bisoprolol (10.8%) frequently prescribed. ACE inhibitors, particularly Enalapril (65.6%), dominated prescriptions. Diuretics, including eplerenone (37.2%) and furosemide (33.3%), ranked third. The majority of patients were male, potentially linked to smoking and alcohol habits. Analysis revealed the prevalence of statins and anti-atherogenic agents in cardiovascular prescriptions. Beta-blockers, ACE inhibitors, and diuretics were prominent in managing hypertension.Top of Form","PeriodicalId":503124,"journal":{"name":"Future Journal of Pharmaceuticals and Health Sciences","volume":"66 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139238635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Background, Trends, Applications and Therapeutic Approaches of Nanoparticles: A Review 纳米粒子的背景、趋势、应用和治疗方法：综述

Future Journal of Pharmaceuticals and Health Sciences Pub Date : 2023-11-19 DOI: 10.26452/fjphs.v3i4.523

Saravanakumar Kasimedu, Hemalatha Palavuri, Swathi Puchakayala, Dhanalakshmi Rayavarapu, Akash Govindan, Harshitha Debbati, Niranjan Babu Mudduluru

引用次数: 0

An Overview of Contemporary Phenotypes, Present Challenges, and Novel Implications for Medical Services in the Diagnosis of Spinal Muscular Atrophy 脊髓肌肉萎缩症诊断中的当代表型、当前挑战和对医疗服务的新影响概述

Future Journal of Pharmaceuticals and Health Sciences Pub Date : 2023-11-19 DOI: 10.26452/fjphs.v3i4.524

Sujana A, Durga Prasad K, Divya E, Kalyani G

引用次数: 0